U.S. Drug Enforcement Administration

Content by U.S. Drug Enforcement Administration

|1 min read

DEA Places Bromazolam in Schedule I, Signaling New Lab Compliance Requirements

Forensic and toxicology labs handling or testing this designer benzodiazepine must follow updated Schedule I regulations
Page 1 of 1